Skip to main content
SpringerLink
Log in

Respiratory Tract Infections

  • Chapter
  • First Online:
Disease Causing Microbes

Abstract

Respiratory tract infections are common, and a major cause of morbidity and mortality around the world. Upper respiratory tract infections include the common cold, laryngitis, pharyngitis/tonsillitis, acute rhinitis, acute rhinosinusitis, and acute otitis media. Viruses are the most dominating organisms infecting upper respiratory tract. Bacterial primary infection or super infection is also encountered. Lower respiratory tract infections include acute bronchitis, bronchiolitis, pneumonia and tracheitis. Bacteria, viruses, and some fungal species may be involved in lower respiratory tract infections. The leading infectious cause of death in children worldwide is lower acute respiratory infection (LARI), particularly pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Garcia-Rodriguez, J. A., & Fresnadillo-Martinez, M. J. (2002). Dynamics of nasopharyngeal colonization by potential respiratory pathogens. Journal of Antimicrobial Chemotherapy, 50(suppl S2), 59–73.

    Google Scholar 

  2. Cooper, R. J., Hoffman, J. R., Bartlett, J. G., et al. (2001). Principles of appropriate antibiotic use for acute pharyngitis in adults: Background. Annals of Internal Medicine, 134, 509–517.

    Article  Google Scholar 

  3. Aagaard, E., & Gonzales, R. (2004). Management of acute bronchitis in healthy adults. Infectious Disease Clinics of North America, 18, 919–937.

    Article  Google Scholar 

  4. Baltimore, R. S. (2010). Re-evaluation of antibiotic treatment of streptococcal pharyngitis. Current Opinion in Pediatrics, 22(1), 77–82.

    Article  Google Scholar 

  5. Hayes, C. S., & Williamson, H. (2001). Management of Group A beta-hemolytic streptococcal pharyngitis. Surg, 72, 560–566.

    Google Scholar 

  6. Dyne, P., & McCartan, K. (2005). Pediatrics, scarlet fever. eMedicine Emergency, 402.

    Google Scholar 

  7. Faé, K. C., da Silva, D. D., Oshiro, S. E., et al. (2006). Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. The Journal of Immunology, 176(9), 5662–5670.

    Article  Google Scholar 

  8. Porth, C. (2007). Essentials of pathophysiology: concepts of altered health states. Lippincott Williams & Wilkins. ISBN 0-7817-7087-4.

    Google Scholar 

  9. Atkinson, W., Hamborsky, J., McIntyre, L., & Wolfe, S. (Eds.). (2007). Diphtheria. In Epidemiology and prevention of vaccine-preventable diseases (The Pink Book) (10 ed., pp. 59–70). Public Health Foundation.

    Google Scholar 

  10. Diphtheria in the Former Soviet Union: Reemergence of a Pandemic Disease. CDC, Emerging Infectious Diseases. 1998-10-01).

    Google Scholar 

  11. World Health Organization. (2006). Diphtheria vaccine—WHO position paper. Weekly Epidemiological Record, 81, 24–31.

    Google Scholar 

  12. Chen, R. T., Broome, C. V., Weinstein, R. A., Weaver, R., & Tsai, T. F. (1985). Diphtheria in the United States, l971–l981. American Journal of Public Health, 75, 1393–1397.

    Google Scholar 

  13. Central Bureau of Health Intelligence. National Health Profile. 2005. Health status indicators: Director General of Health Services, Government of India; Ministry of Health & Family Welfare Nirman Bhawan, New Delhi. Available from http://cbhidghs.nic.in/CBHI%20Book/chapter3.pdf

  14. Bitragunta, S., Murhekar, M. V., Hutin, Y. J., Penumur, P. P., & Gupte, M. D. (2008). Persistence of diphtheria, Hyderabad, India, 2003–2006. Emerging Infectious Diseases, 14, 1144–1146.

    Article  Google Scholar 

  15. Lodha, R., Dash, N., Kapil, A., & Kabra, S. K. (2000). Diphtheria in urban slums in North India. Lancet, 355, 204.

    Article  Google Scholar 

  16. Diphtheria Mechanism (2010, October 7). The medical news. Web. http://www.news-medical.net/health/Diphtheria-Mechanism.aspx

  17. Paradise, J. L., Rockette, H. E., Colborn, D. K., et al. (1997). Otitis media in 2253 Pittsburgh-area infants: Prevalence and risk factors during the first two years of life. Pediatrics, 99, 318–333.

    Article  Google Scholar 

  18. Erramouspe, J., & Heyneman, C. A. (2000). Treatment and prevention of otitis media. Annals of Pharmacotherapy, 34, 1452–1468.

    Article  Google Scholar 

  19. Heikkinen, T., & Järvinen, A. (2003). The common cold. Lancet, 361(9351), 51–59.

    Article  Google Scholar 

  20. Eccles, R. (2005). Understanding the symptoms of the common cold and influenza. The Lancet Infectious Diseases, 5, 718–725.

    Article  Google Scholar 

  21. Abraham, G., & Colonno, R. J. (1984). Many rhinovirus serotypes share the same cellular receptor. Journal of Virology, 51, 340–345.

    Article  Google Scholar 

  22. Winther, B. (2011). Rhinovirus infections in the upper airway. Proceedings of the American Thoracic Society, 8(1), 79–89.

    Article  Google Scholar 

  23. Aronson, M. D., Weiss, S. T., Ben, R. L., & Komaroff, A. L. (1982). Association between cigarette smoking and acute respiratory tract illness in young adults. JAMA, 248, 181–183.

    Article  Google Scholar 

  24. Cohen, S., Doyle, W. J., Alper, C. M., Janicki-Deverts, D., & Turner, R. B. (2009). Sleep habits and susceptibility to the common cold. Archives of Internal Medicine, 169, 62–67.

    Article  Google Scholar 

  25. Eccles, R. (2002). Acute cooling of the body surface and the common cold. Rhinology, 40, 109–114.

    Google Scholar 

  26. Mourtzoukou, E. G., & Falagas, M. E. (2007). Exposure to cold and respiratory tract infections. International Journal of Tuberculosis & Lung Disease, 11, 938–943.

    Google Scholar 

  27. Gwaltney, J. M., & Druce, H. M. (1997). Efficacy of brompheniramine maleate for the treatment of rhinovirus colds. Clinical Infectious Diseases, 25, 1188–1194.

    Article  Google Scholar 

  28. Watson, D. A., Musher, D. M., Jacobson, J. W., & Verhoef, J. (1993). A brief history of the pneumococcus in biomedical research: A panoply of scientific discovery. Clinical Infectious Diseases, 17, 913–924.

    Article  Google Scholar 

  29. Avery, O. T., Macleod, C. M., & McCarty, M. (1944). Studies on the chemical nature of the substance inducing transformation of pneumococcal serotypes: Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. Journal of Experimental Medicine, 79, 137–157.

    Article  Google Scholar 

  30. Baker, P. J. (1990). Regulation of the magnitude of the antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes. Infection and Immunity, 58, 3465–3468.

    Article  Google Scholar 

  31. Felton, M. D., Kauffmam, G., Prescott, B., & Ottinger, B. (1955). Studies on the mechanism of immunological paralysis induced in mice by pneumococcal polysaccharides. The Journal of Immunology, 74, 17–26.

    Article  Google Scholar 

  32. Martinez-Hernandez, D., & Bouza. E. (1992). Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Journal of Infectious Disease, 14, 427–435.

    Google Scholar 

  33. Gillespie, S. H. (1989). Aspects of pneumococcal infection including bacterial virulence, host response and vaccination. Journal of Medical Microbiology, 28, 237–248.

    Article  Google Scholar 

  34. Gray, B. M., Converse, G. M., III., & Dillon, H. C., Jr. (1979). Serotypes of Streptococcus pneumoniae causing disease. Journal of Infectious Diseases, 140, 979–983.

    Article  Google Scholar 

  35. Black, R. E., Morris, S. S., & Bryce, J. (2003). Where and why are 10 million children dying every year? The Lancet, 361, 2226–2234.

    Article  Google Scholar 

  36. Coles, C. L., Kanungo, R., Rahmathullah, L., Thulasiraj, R. D., Katz, J., Santosham, M., et al. (2001). Pneumococcal nasopharyngeal colonization in young South Indian infants. The Pediatric Infectious Disease Journal, 20, 289–295.

    Article  Google Scholar 

  37. Ehrenworth, L., & Baer, H. (1956). The pathogenicity of Klebsiella pneumoniae for mice: The relationship to the quantity and rate of production of type specific capsular polysaccharide. Journal of Bacteriology, 72, 713–717.

    Article  Google Scholar 

  38. Highsmith, A. K., William, R., & Jarvis, W. R. (1985). Klebsiella pneumoniae: Selected virulence factors that contribute to pathogenicity. Infection Control, 6, 75–77.

    Article  Google Scholar 

  39. Yu, V. L., Hansen, D. S., Ko, W. C., Sagnimeni, A., Klugman, K. P., von Gottberg, A., Goossens, H., Wagener, M. M., Benedi, V. J., & International Klebseilla Study Group. (2007). Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerging Infectious Disease, 13, 986–993.

    Google Scholar 

  40. Fung, C. P., Chang, F. Y., Lee, S. C., Hu, B. S., Kuo, B. I., & Liu, C. Y. (2002). A global emerging disease of Klebsiella pneumoniae liver abscess: Is serotype K1 an important factor for complicated endophthalmitis? Gut, 50, 420–424.

    Article  Google Scholar 

  41. Wang, J. H., Liu, Y. C., Lee, S. S., Yen, M. Y., Chen, Y. S., & Wang, J. H. (1998). Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clinical Infectious Diseases, 26, 1434–1438.

    Article  Google Scholar 

  42. Foy, H. M. (1993). Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clinical Infectious Disease, 1, S37-46.

    Article  Google Scholar 

  43. Wright, S. W. (1998). Pertussis infection in adults. Southern Medical Journal, 91, 702.

    Article  Google Scholar 

  44. Guiso, N. (2009). Bordetella pertussis and pertussis vaccines. Clinical Infectious Diseases, 49, 1565–1569.

    Article  Google Scholar 

  45. Hewlett, E. L., Donato, G. M., & Gray, M. C. (2006). Macrophage cytotoxicity produced by adenylate cyclase toxin from Bordetella pertussis: More than just making cyclic AMP. Molecular Microbiology, 59(2), 447–459.

    Article  Google Scholar 

  46. Cherry, J. D., & Heininger, U. (2004). Pertussis and other Bordetella infections. In R. D. Feigin, J. D. Cherry, G. J. Demmler, & S. Kaplan (Eds.), Textbook of pediatric infectious diseases (5th ed., pp. 1588–1608). The W. B. Saunders Co.

    Google Scholar 

  47. Kerr, J. R., & Preston, N. W. (2001). Current pharmacotherapy of pertussis. Expert Opinion on Pharmacotherapy, 2, 1275–1282.

    Article  Google Scholar 

  48. von Konig, W. (2005). The pediatric. Infectious Disease Journal, 24, S66–S68 (Use of Antibiotics in Pertussis).

    Google Scholar 

  49. CDC. (1995). Pertussis—United States, January 1992–June 1995. Morbidity and Mortality Weekly Report, 44, 525–529.

    Google Scholar 

  50. CDC. (2006). Preventing tetanus, diphtheria, and pertussis among adults: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Morbidity and Mortality Weekly Report, 55, 1–33.

    Google Scholar 

  51. van Soolingen, D., Hoogenboezem, T., de Haas, P. E., et al. (1997). A novel Pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: Characterization of an exceptional isolate from Africa. International Journal of Systematic Bacteriology, 47, 1236.

    Article  Google Scholar 

  52. Verhoef, J. (1991). Host-pathogen relationships in respiratory tract infections. Clinical Therapeutics, 13, 172–180.

    Google Scholar 

  53. Lönnroth, K., & Raviglione, M. (2008). Global epidemiology of tuberculosis: Prospects for control. Semin Respir Crit Care Med., 29, 481.

    Article  Google Scholar 

  54. WHO. (2008). Global tuberculosis control. WHO/HTM/TB/2008.393. World Health Organization. Available online at http://www.who.int/tb/publications/global_report/2008/en/index.html

  55. Chakraborty, A. K. (2004). Epidemiology of tuberculosis: Current status in India. Indian Journal of Medical Research, 120, 248–276.

    Google Scholar 

  56. Williams, B. G., Granich, R., Chauhan, L. S., Dharmshaktu, N. S., & Dye, C. (2005). The impact of HIV/AIDS on the control of tuberculosis in India. Proceedings of National Academy of Sciences of USA, 102, 9619–9624.

    Article  Google Scholar 

  57. World Health Organization. (2000). Anti-tuberculosis drug resistance in the world. Prevalence and trends. WHO/CDS/TB/2000/.278 The WHO/IUATLD. Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Report 2. World Health Organization, Geneva, Switzerland.

    Google Scholar 

  58. Meacci, F., Orrù, G., Iona, E., Giannoni, F., Piersimoni, C., Pozzi, G., Fattorini, L., & Oggioni, M. R. (2005). Drug resistance evolution of a Mycobacterium tuberculosis strain from a noncompliant patient. Journal of Clinical Microbiology, 43, 3114–3120.

    Article  Google Scholar 

  59. Prasad, R. (2005). Current MDR status. The Indian Journal of Tuberculosis, 52, 121–131.

    Google Scholar 

  60. World Health Organization. (2006). Global tuberculosis control: WHO report. WHO/HTM/TB/2006.362.

    Google Scholar 

  61. Shah, N. S., Wright, A., Bai, G. H., Barerra, L., Boulahbal, F., Casabona, N., et al. (2007). Worldwide emergence of extensively drug-resistant tuberculosis. Emerging Infectious Diseases, 13, 380–387.

    Article  Google Scholar 

  62. Mondal, R., & Jain, A. (2007). Extensively drug-resistant Mycobacterium tuberculosis, India. Emerging Infectious Disease, 13, 1429–1431.

    Article  Google Scholar 

  63. Colditz, G. A., Brewer, T. F., Berkey, C. S., Wilson, M. E., Burdick, E., Fineberg, H. V., Mosteller, F. (1994). Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA, 271, 698–702.

    Google Scholar 

  64. Chan, E. D., & Iseman, M. D. (2002). Current medical treatment for tuberculosis. BMJ, 325, 1282–1286.

    Article  Google Scholar 

  65. Stedwell, R. E., Allen, K. M., & Binder, L. S. (1992). Hypokalemic paralyses: A review of the etiologies, pathophysiology, presentation, and therapy. American Journal of Emergency Medicine, 110, 143–148.

    Article  Google Scholar 

  66. Aagaard, C., Hoang, T., Dietrich, J., Cardona, P. J., Izzo, A., Dolganov, G., Schoolnik, G. K., Cassidy, J. P., Billeskov, R., & Andersen, P. (2011). A multistage tuberculosis vaccine that confers efficient protection before and after exposure. Nature Medicine, 217, 189–194.

    Article  Google Scholar 

  67. Swanson, M., Heuner, K. (2008). Legionella: Molecular microbiology. Caister Academic Press. ISBN 1-904455-26-3.

    Google Scholar 

  68. http://www.osha.gov/SLTC/legionnairesdisease/index.html. Safety and Health Topics: Legionnaires’ Disease.

  69. Stout, J. E., Muder, R. R., et al. (2007). Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: A national surveillance study with clinical correlations. Infection Control and Hospital Epidemiology, 28, 818–824.

    Article  Google Scholar 

  70. van Woensel, J. B., van Aalderen, W. M., & Kimpen, J. L. (2003). Viral lower respiratory tract infection in infants and young children. BMJ, 327, 36–40.

    Article  Google Scholar 

  71. Jennings, L. C., Anderson, T. P., Werno, A. M., Beynon, K. A., & Murdoch, D. R. (2004). Viral etiology of acute respiratory tract infections in children presenting to hospital: Role of polymerase chain reaction and demonstration of multiple infections. The Pediatric Infectious Disease Journal, 23, 1003–1007.

    Article  Google Scholar 

  72. van den Hoogen, B. G., de Jong, J. C., Groen, J., Kuiken, T., de Groot, R., & Fouchier, R. A. (2001). A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nature Medicine, 7, 719–724.

    Article  Google Scholar 

  73. Crowe, J. E., Jr. (2004). Human metapneumovirus as a major cause of human respiratory tract disease. The Pediatric Infectious Disease Journal, 23(Suppl. 11), S215–S221.

    Article  Google Scholar 

  74. Smith, N. M., Bresee, J. S., Shay, D. K., Uyeki, T. M., Cox, N. J., & Strikas, R. A. (2006). Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP). Morbidity and Mortality Weekly Report. Centers for Disease Control and Prevention.

    Google Scholar 

  75. Ampel, N. (2005). Coccidioidomycosis in persons infected with HIV type 1. Clinical Infectious Diseases, 41, 1174–1178.

    Article  Google Scholar 

  76. Schneider, E., Hajjeh, R. A., Spiegel, R. A., et al. (1997). A coccidioidomycosis outbreak following the Northridge, Calif, earthquake. JAMA, 277(11), 904–908.

    Article  Google Scholar 

  77. Barron, M. A., & Madinger, N. E. (2008). Opportunistic fungal infections, Part 3: Cryptococcosis, histoplasmosis, coccidioidomycosis, and emerging mould infections. Infections in Medicine 2008 UBM Medical LLC, London, UK.

    Google Scholar 

  78. Ryan, K. J., & Ray, C. G. (Ed.). (2004). Sherris medical microbiology (4th ed., pp. 674–676). McGraw Hill. ISBN 0-8385-8529-9.

    Google Scholar 

  79. Duboucher, C., et al. (2006). Molecular identification of Tritrichomonas foetus-like organisms as coinfecting agents of human Pneumocystis pneumonia. Journal of Clinical Microbiology, 44, 1165–1168.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Former Professor, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India

    Jaishree Paul

Authors
  1. Jaishree Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jaishree Paul .

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s)

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Paul, J. (2024). Respiratory Tract Infections. In: Disease Causing Microbes. Springer, Cham. https://doi.org/10.1007/978-3-031-28567-7_3

Download citation

Publish with us

Policies and ethics

Search

Navigation